Clinical Trial

Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 1, 2022 (before its estimated May 31, 2022 completion). Its status may not reflect the trial's current state.
Summary
This study is intended to provide information from subjects who currently have painful, chronically open wounds and assess the pain reduction capacity of KeraStat® Gel with Morphine. In gathering data from subjects who have baseline pain from their chronically open wounds, the investigators can then evaluate the capacity of KeraStat® Gel plus Morphine in reducing the subjects daily pain levels, pain associated with dressing changes, and pain medication consumption.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-01-19.
Status change: Recruiting → Terminated 2024-10-17
Trial Details
NCT Number NCT05217160
Lead Sponsor The Metis Foundation
Conditions Wound of Skin, Burns
Enrollment 24 participants
Start Date 2021-05-11
Primary Completion 2022-05-31 (estimated)
Study Completion 2022-05-31 (estimated)
Updated on ClinicalTrials.gov 2022-02-01